More Data and Appropriate Statistical Methods Needed to Fully Measure the Displacement Effects of Development Assistance for Health
article has not abstract
Published in the journal:
. PLoS Med 10(1): e32767. doi:10.1371/journal.pmed.1001365
Category:
Perspective
doi:
https://doi.org/10.1371/journal.pmed.1001365
Summary
article has not abstract
Linked Perspective Articles
Batniji R, Bendavid E (2013) Considerations in Assessing the Evidence and Implications of Aid Displacement from the Health Sector. PLoS Med 10(1): e1001364. doi:10.1371/journal.pmed.1001364
Murray CJL, Dieleman JL, Lu C, Hanlon M (2013) More Data and Appropriate Statistical Methods Needed to Fully Measure the Displacement Effects of Development Assistance for Health. PLoS Med 10(1): e1001365. doi:10.1371/journal.pmed.1001365
The question of whether foreign aid results in recipient governments spending less on health is an enduring concern in global health. In separate analyses, Farag et al. and Lu et al., which included members of our group (CL, CM), found compelling evidence of “aid displacement," meaning a substitution between development assistance for health from foreign donors and health expenditure financed by domestic sources [1],[2] We reported that for every dollar a government received in development assistance for health, the government's domestic expenditure on health decreased by $0.46 (95% confidence interval: 0.24, 0.67) [2]. Subsequent research questioned those findings [3]–[6], including Batniji and Bendavid in PLOS Medicine who have since admitted mistakes in their statistical model [4]. We argue that these subsequent studies fail to account for the complex, dynamic connection between domestic and foreign funding sources. Estimating this relationship requires detailed data on both flows of resources and how national resources are allocated along with the appropriate statistical method. Given the analytical challenges, it is imperative that more data be available and appropriate methods be used, so that the impact of development assistance can be better understood.
Future Research
Methodologists will continue to debate how best to model this relationship, but the prevailing evidence is clear that on average displacement is occurring, and, at a minimum, reductions in government health expenditure are significantly associated with increases in development assistance channeled to the government. The next challenges are to (a) further substantiate this effect and (b) unpack the average effect so that we better understand the subtle but important characteristics of this behavior. Important research questions should answer when and where aid displacement is greatest. Current models presume countries to be financially stationary by assuming that all the non-modeled time-variant effects do not systematically affect government health expenditure. This may not be the case. Furthermore, the degree of displacement may vary across several dimensions. Future analyses should consider if the rate of displacement changes over time or across health financing scheme or aid focus areas. Finally, the rate of replacement caused by aid decreases might not equal the rate of displacement caused by aid increases. In other words, it is unknown if the displacement effect is symmetric. The answers to all these questions would dramatically influence the long-term impact of development assistance for health.
In the long run, it is unclear how displacement between development assistance and government spending affects societal welfare. For example, funds may be reallocated from health to the education sector, which also has the potential to generate social value. Due to limited data, we have no meaningful knowledge of how displaced funds are reallocated and how much social value is generated by alternate activities. Since government resources are often not ear-marked, displacement in the health sector may have non-trivial effects on a host of sectors. This ambiguity highlights the need for better data on both development assistance and government expenditure across sectors.
What Data Exist, and What Data Are Needed
Data from three financial flows can significantly improve our understanding of aid displacement: (i) development assistance, disaggregated by sector (health, education, et cetera) and recipient agent (government or non-government); (ii) government expenditure, disaggregated by sector; and (iii) governmental tax revenues. To thoroughly address this question, these data series would be required at the country-year level. If these data existed and expected resources could be tracked across sectors, then researchers, donors, and policy makers would have much clearer insight on the displacement of various funding streams, and begin to explore the effect of that behavior on population welfare.
As a practical matter, some elements of each of these series are currently unavailable. The Institute for Health Metrics and Evaluation (IHME) regularly publishes policy reports on development assistance or health [7]–[10]. The underlying data for these reports are disaggregated by funding sources, channels of assistance, implementing institutions, recipient countries, and health focus areas, and are publically available at the IHME Global Health Data Exchange [11]. The Development Assistance Committee (DAC) of the Organisation for Economic Co-operation and Development maintains the Creditor Reporting System (CRS), which reports project-level information about official development assistance, other official flows, and some private assistance [12]. The CRS provides most—but not all—of the information necessary to estimate the total amount of development assistance across all sectors. To supplement the CRS, researchers would need to solicit data from bilateral donors, multilateral agencies, and relevant non-governmental organizations that do not actively participate in the DAC. This would be an intensive process, especially to disaggregate the total by sector, but it is akin to how IHME generates its series for development assistance to health.
Government health expenditure is reported by the World Health Organization (WHO), although that estimate comingles domestically generated funds with development assistance for health channeled through the government [13]. By subtracting the amount of development assistance channeled to the government in a given year, we can estimate a first approximation of governmental health expenditure from domestically generated sources. The International Monetary Fund (IMF) reports for some countries on total government expenditures [14]. The main challenge is that the IMF Government Finance Statistics provide a breakdown of government spending by sector for very few countries. Despite the urgency of understanding how development assistance affects government spending patterns, improvements in tracking government spending by sector are not currently a priority.
Even tracking total government tax revenues is a challenge. The most reliable sources of revenue data are from IMF surveillance documents and in particular the Article IV consultation reports [15]. From 1998 to 2012, a total of 1,581 reports from 188 countries are publicly available (which implies 40% of this series' country years are either unavailable or missing). One strategy to complete these series would be to use a variety of data sources, such as national account matrices and household budget surveys, to triangulate on an estimate of the true value. The statistical techniques to accomplish this estimation are well established (a recent example is estimating the ownership of insecticide-treated bed nets [16]). However, the task of compiling the complementary data is not trivial, and it would require the commitment of funding from donors interested in thoroughly addressing the issue of how displacement affects social welfare.
On average, the evidence is that a tradeoff exists between development assistance channeled to the government health sector and health expenditure financed by domestic sources. To better understand this phenomenon, documentation of how governments spend their own resources by sector is an urgent priority. Improved data, which is in the interest of governments, donors, and concerned citizens alike, will need a concerted effort by the development community. Further improvements in data and the appropriate statistical methods should lead to more rigorous and detailed analyses of the total impact of development assistance.
Zdroje
1. FaragM, NandakumarA, WallackSS, GaumerG, HodgkinD (2009) Does funding from donors displace government spending for health in developing countries? Health Aff 28L: 1045–1055.
2. LuC, SchneiderMT, GubbinsP, Leach-KemonK, JamisonD, et al. (2010) Public financing of health in developing countries: a cross-national systematic analysis. Lancet 375: 1375–1387 doi:10.1016/S0140-6736(10)60233-4.
3. GargCC, EvansDB, DmytraczenkoT, Izazola-LiceaJ-A, TangcharoensathienV, et al. (2012) Study raises questions about measurement of ‘additionality,’ or maintaining domestic health spending amid foreign donations. Health Aff 31: 417–425.
4. BatnijiR, BendavidE (2012) Retraction: Does development assistance for health really displace government health spending? Reassessing the evidence. PLoS Med 9 (5) e1001214 doi:10.1371/journal.pmed.1001214.
5. RoodmanD (2012) Doubts about the evidence that foreign aid for health is displaced into non-health uses. Lancet 380: 972–973 doi:10.1016/S0140-6736(12)61529-3.
6. MurrayCJL (2012) Doubts about the evidence that foreign aid for health is displaced into non-health uses – author's reply. Lancet 380: 972–973 doi:10.1016/S0140-6736(12)61530-X.
7. RavishankarN, GubbinsP, CooleyRJ, Leach-KemonK, MichaudCM, et al. (2009) Financing of global health: tracking development assistance for health from 1990 to 2007. Lancet 373: 2113–2124 doi:10.1016/S0140-6736(09)60881-3.
8. Institute for Health Metrics and Evaluation (2009) Financing global health 2009: tracking development assistance for health. Seattle: IHME. http://www.healthmetricsandevaluation.org/publications/policy-report/financing-global-health-2009-tracking-development-assistance-health. Accessed 7 November 2012.
9. Institute for Health Metrics and Evaluation (2010) Financing global health 2010: development assistance and country spending in economic uncertainty. Seattle: IHME. http://www.healthmetricsandevaluation.org/publications/policy-report/financing_global_health_2010_IHME. Accessed 7 November 2012.
10. Institute for Health Metrics and Evaluation. Financing Global Health 2011: Continued Growth as MDG Deadline Approaches. Seattle: IHME, 2011. http://www.healthmetricsandevaluation.org/publications/policy-report/financing-global-health-2011-continued-growth-mdg-deadline-approaches. Accessed 7 November 2012.
11. Institute for Health Metrics and Evaluation. Global Health Data Exchanged. Available: http://www.healthmetricsandevaluation.org/ghdx/record/development-assistance-health-country-and-regional-recipient-level-database-1990-2009 and http://www.healthmetricsandevaluation.org/ghdx/record/development-assistance-health-database-1990-2009. Accessed 7 November 2012.
12. Organisation for Economic Cooperation and Development. User's guide to the Creditor Reporting System (CRS) Aid Activities database. Available: http://www.oecd.org/dac/aidstatistics/usersguidetothecreditorreportingsystemcrsaidactivitiesdatabase.htm. Accessed 7 November 2012.
13. World Health Organization. World Health Statistics. WHO: Geneva. Available: http://apps.who.int/gho/data/. Accessed 7 November 2012.
14. International Monetary Fund. Government Financial Statistics. Available: http://www.imf.org/external/data.htm#data. Accessed 7 November 2012.
15. International Monetary Fund. IMF Surveillance. Available: http://www.imf.org/external/np/exr/facts/surv.htm. Accessed 7 November 2012.
16. FlaxmanAD, FullmanN, OttenMWJr, MenonM, CibulskisRE, et al. (2010) Rapid scaling up of insecticide-treated bed net coverage in Africa and its relationship with development assistance for health: a systematic synthesis of supply, distribution, and household survey data. PLoS Med 7 (8) e1000328 doi:10.1371/journal.pmed.1000328.
Štítky
Interní lékařstvíČlánek vyšel v časopise
PLOS Medicine
2013 Číslo 1
- Není statin jako statin aneb praktický přehled rozdílů jednotlivých molekul
- Testování hladin NT-proBNP v časné diagnostice srdečního selhání – guidelines ESC
- Cinitaprid – v Česku nová účinná látka nejen pro léčbu dysmotilitní dyspepsie
- Moje zkušenosti s Magnosolvem podávaným pacientům jako profylaxe migrény a u pacientů s diagnostikovanou spazmofilní tetanií i při normomagnezémii - MUDr. Dana Pecharová, neurolog
- Antikoagulační léčba u pacientů před operačními výkony
Nejčtenější v tomto čísle
- Differences in Reporting of Analyses in Internal Company Documents Versus Published Trial Reports: Comparisons in Industry-Sponsored Trials in Off-Label Uses of Gabapentin
- The Effectiveness of Mobile-Health Technologies to Improve Health Care Service Delivery Processes: A Systematic Review and Meta-Analysis
- The Effectiveness of Mobile-Health Technology-Based Health Behaviour Change or Disease Management Interventions for Health Care Consumers: A Systematic Review
- Why Do Women Not Use Antenatal Services in Low- and Middle-Income Countries? A Meta-Synthesis of Qualitative Studies